Alendronic acid - PDFSEARCH.IO - Document Search Engine

Alendronic acid
Results: 402

#	Item
31	Table 11(b):Significant Drugs (incl Drs Bag)-Sorted by Highest Volume Change, year end: Jun 2006 to year end: JunYear ending Jun 2006 Rank Drug Year ending Jun 2007 Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-01-19 18:01:25 Bisphosphonates Azetidines Ezetimibe Lactams Organofluorides Sodium Alendronic acid Rosuvastatin Risedronic acid Chemistry Organic chemistry Merck
32	Table 8(a):Significant drugs (incl Drs bag)-sorted by highest change to Government cost, year end: Jun 2010 to year end: JunSection 85 Only Year ending Jun 2010 Rank Drug Volume Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-01-19 18:01:25 Amines Amlodipine Dihydropyridines Ethers Perindopril Alendronic acid Sodium Risedronic acid Total cost Chemistry Organic chemistry Bisphosphonates
33	SCHEDULE OF PHARMACEUTICAL BENEFITS SUMMARY OF CHANGES EFFECTIVE 1 April 2015 Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-03-24 19:27:57 Benzimidazoles Proton pump inhibitors Pyridines Sulfoxides Pharmacology Omeprazole Alendronic acid V Esomeprazole Chemistry Organic chemistry AstraZeneca
34	Table 8(b):Significant Drugs (incl Drs Bag)-Sorted by highest volume change, year end: Jun 2010 to year end: JunSection 85 Only Year ending Jun 2010 Rank Drug Volume Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-01-19 18:01:25 Bisphosphonates Calcium channel blockers Amlodipine Dihydropyridines Ethers Perindopril Alendronic acid Valsartan Angiotensin II receptor antagonist Chemistry Organic chemistry Organochlorides
35	New therapies in osteoporosis Dr H Zeimer Department endocrinology & diabetes St Vincent’s hospital Current therapies Add to Reading List Source URL: www.grampiansml.com.au Language: English - Date: 2013-10-28 19:22:55 Drugs Osteopathies Macrophages Osteoclast Osteoporosis Cathepsin Alendronic acid Bone Denosumab Biology Peptidase Bisphosphonates
36	Atlas of Healthcare Variation Methodology \| Falls General points:  Data are not presented where the number of people was less than 10. This is to preserve confidentiality.  People were assigned to their district he Add to Reading List Source URL: www.hqsc.govt.nz Language: English - Date: 2015-04-09 17:45:05 Bisphosphonate Alendronic acid Hip replacement Medicine Bone fractures Hip fracture
37	Microsoft Word - acl201014iNZ Add to Reading List Source URL: www.hqsc.govt.nz Language: English - Date: 2015-03-29 22:31:11 Osteopathies Osteoporosis Aclasta Zoledronic acid Hip fracture Hypercalcaemia Osteonecrosis of the jaw Vitamin D Alendronic acid Medicine Health Bisphosphonates
38	MSAC application no 1313 Bone mineral density analyses using Dual Energy X-ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment June 2014 Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2015-04-09 02:11:13 Dual-energy X-ray absorptiometry Radiology AstraZeneca Osteoporosis Bone density Zoledronic acid Denosumab Alendronic acid Tamoxifen Medicine Bisphosphonates Aromatase inhibitors
39	VOL 9 ISSUE 2 NEWSLETTER July 2010 Add to Reading List Source URL: www.ortho.hku.hk Language: English - Date: 2011-05-30 01:12:08 Osteoporosis Osteoclast Osteoprotegerin Orthopedic surgery Bone remodeling University of Hong Kong Alendronic acid Bone Biology Medicine Osteopathies
40	SCHEDULE OF PHARMACEUTICAL BENEFITS SUMMARY OF CHANGES EFFECTIVE 1 April 2015 Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-24 19:27:57 Benzimidazoles Proton pump inhibitors Pyridines Sulfoxides Pharmacology Omeprazole Alendronic acid V Esomeprazole Chemistry Organic chemistry AstraZeneca